JP2015508780A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508780A5 JP2015508780A5 JP2014557870A JP2014557870A JP2015508780A5 JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5 JP 2014557870 A JP2014557870 A JP 2014557870A JP 2014557870 A JP2014557870 A JP 2014557870A JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- composition
- administering
- immunocompromised patients
- inhaler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010061598 Immunodeficiency Diseases 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 229940071648 metered dose inhaler Drugs 0.000 claims 2
- 239000007922 nasal spray Substances 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 206010054979 Secondary immunodeficiency Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- 229940112141 dry powder inhaler Drugs 0.000 claims 1
- 238000002650 immunosuppressive therapy Methods 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229940097496 nasal spray Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600545P | 2012-02-17 | 2012-02-17 | |
| US61/600,545 | 2012-02-17 | ||
| US201261727627P | 2012-11-16 | 2012-11-16 | |
| US61/727,627 | 2012-11-16 | ||
| PCT/US2013/026754 WO2013123521A1 (en) | 2012-02-17 | 2013-02-19 | Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015508780A JP2015508780A (ja) | 2015-03-23 |
| JP2015508780A5 true JP2015508780A5 (enExample) | 2016-04-21 |
Family
ID=48984833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557870A Pending JP2015508780A (ja) | 2012-02-17 | 2013-02-19 | 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20130280332A1 (enExample) |
| EP (1) | EP2841092B1 (enExample) |
| JP (1) | JP2015508780A (enExample) |
| CN (2) | CN109529026A (enExample) |
| AU (3) | AU2013221230A1 (enExample) |
| CA (1) | CA2864746A1 (enExample) |
| ES (1) | ES2970401T3 (enExample) |
| IL (2) | IL234116B (enExample) |
| WO (1) | WO2013123521A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2799403C (en) | 2010-05-14 | 2020-01-21 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating leukemia |
| BR112012029005A2 (pt) | 2010-05-14 | 2016-07-26 | Dana Farber Cancer Inst Inc | composições e métodos de tratamento de neoplasia, doença inflamatória e outros distúrbios |
| US9301962B2 (en) | 2010-05-14 | 2016-04-05 | Baylor College Of Medicine | Male contraceptive compositions and methods of use |
| BR112016001457A2 (pt) | 2013-07-25 | 2017-08-29 | Dana Farber Cancer Inst Inc | Inibidores de fatores de transcrição e usos dos mesmos |
| CN105849110B (zh) | 2013-11-08 | 2019-08-02 | 达纳-法伯癌症研究所有限公司 | 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法 |
| WO2015117053A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Diaminopyrimidine benzenesulfone derivatives and uses thereof |
| JP2017504651A (ja) | 2014-01-31 | 2017-02-09 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | ジアゼパン誘導体の使用 |
| MX377534B (es) | 2014-02-28 | 2025-03-10 | Tensha Therapeutics Inc | Compuestos para usarse en el tratamiento de hiperinsulinemia. |
| EP3177147A4 (en) | 2014-08-08 | 2018-01-24 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| BR112017002369A2 (pt) | 2014-08-08 | 2017-12-05 | Dana Farber Cancer Inst Inc | derivados de diazepana e usos dos mesmos |
| WO2016069578A1 (en) | 2014-10-27 | 2016-05-06 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
| US20190000860A1 (en) * | 2014-11-06 | 2019-01-03 | Dana-Farber Cancer Institute, Inc. | Use of compositions modulating chromatin structure for graft versus host disease (gvhd) |
| EP3885343A1 (en) | 2014-11-06 | 2021-09-29 | Dana-Farber Cancer Institute, Inc. | Indole compounds as ezh2 inhibitors and uses thereof |
| US20180177852A1 (en) * | 2015-06-08 | 2018-06-28 | Ansun Biopharma, Inc. | Treatment of human metapneumovirus |
| EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS |
| CN108472300A (zh) | 2015-09-11 | 2018-08-31 | 达纳-法伯癌症研究所股份有限公司 | 氰基噻吩并三唑并二氮杂环庚三烯及其用途 |
| AU2016319785C1 (en) | 2015-09-11 | 2021-04-01 | Dana-Farber Cancer Institute, Inc. | Acetamide thienotriazolodiazepines and uses thereof |
| KR20180081809A (ko) | 2015-11-25 | 2018-07-17 | 다나-파버 캔서 인스티튜트 인크. | 2가 브로모도메인 억제제 및 그의 용도 |
| CA3018270A1 (en) | 2016-04-22 | 2017-10-26 | Dana-Farber Cancer Institute, Inc. | Ezh2 inhibitors and uses thereof |
| JP2023502776A (ja) * | 2019-11-25 | 2023-01-25 | アンサン バイオファーマ， インク． | 癌細胞、免疫細胞および腫瘍微小環境へのシアリダーゼの免疫細胞送達 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
| WO2004022128A2 (en) * | 2002-09-06 | 2004-03-18 | Chrysalis Technologies Incorporated | Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| AU2003294401C1 (en) | 2002-11-22 | 2008-09-18 | Ansun Biopharma, Inc. | Broad spectrum anti-viral therapeutics and prophylaxis |
| CA2932997C (en) * | 2006-01-24 | 2019-07-30 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
-
2013
- 2013-02-19 AU AU2013221230A patent/AU2013221230A1/en not_active Abandoned
- 2013-02-19 US US13/770,991 patent/US20130280332A1/en not_active Abandoned
- 2013-02-19 JP JP2014557870A patent/JP2015508780A/ja active Pending
- 2013-02-19 ES ES13749329T patent/ES2970401T3/es active Active
- 2013-02-19 CA CA2864746A patent/CA2864746A1/en not_active Abandoned
- 2013-02-19 EP EP13749329.2A patent/EP2841092B1/en active Active
- 2013-02-19 CN CN201811368987.7A patent/CN109529026A/zh active Pending
- 2013-02-19 CN CN201380009763.6A patent/CN104203267A/zh active Pending
- 2013-02-19 WO PCT/US2013/026754 patent/WO2013123521A1/en not_active Ceased
-
2014
- 2014-08-13 IL IL234116A patent/IL234116B/en active IP Right Grant
-
2015
- 2015-01-26 US US14/605,572 patent/US20150132274A1/en not_active Abandoned
-
2017
- 2017-02-10 US US15/430,288 patent/US20170151315A1/en not_active Abandoned
- 2017-11-10 AU AU2017258955A patent/AU2017258955A1/en not_active Abandoned
-
2019
- 2019-09-05 AU AU2019226190A patent/AU2019226190B2/en not_active Ceased
-
2020
- 2020-03-10 IL IL273194A patent/IL273194B2/en unknown
- 2020-07-31 US US16/945,776 patent/US20210046165A1/en not_active Abandoned
-
2025
- 2025-01-21 US US19/033,237 patent/US20250387457A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508780A5 (enExample) | ||
| IL273194B2 (en) | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients | |
| BR112013028572B8 (pt) | Bocais para distribuição de droga nasal | |
| PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
| IL216468B (en) | Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate and formoterol and their use in treatment of pulmonary diseases | |
| CN204502085U (zh) | 呼吸内科用喷药器 | |
| PH12014500551A1 (en) | Pharmaceutical composition for inhalation | |
| MX377175B (es) | Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc). | |
| JP2014528470A5 (enExample) | ||
| MX2021006585A (es) | Ciclosporina a en forma solubilizada en liposomas (l-csa) para usarse en el tratamiento de enfermedades pulmonares mediante la inhalación de un aerosol generado por un nebulizador. | |
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| JP2014530231A5 (enExample) | ||
| EA202091199A1 (ru) | Лекарственное средство для предотвращения или лечения риновирусной инфекции | |
| NZ600208A (en) | Inhalation solutions | |
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| CN204092782U (zh) | 一种医用雾化器 | |
| JP2013522295A5 (enExample) | ||
| CN204233551U (zh) | 辅助呼吸气雾气体的装置 | |
| CN203029815U (zh) | 呼吸内科用给药器 | |
| EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка | |
| PH12020552075A1 (en) | Hepatitis b vaccine transnasal administration system | |
| AR094287A1 (es) | Metodos y composiciones para administracion de oxibutinina | |
| EP4005565A1 (en) | Novel uses of adamantane derivatives | |
| CN203802906U (zh) | 用于呼吸疾病治疗的雾化吸氧给药器 | |
| CN203436639U (zh) | 一种雾化器 |